NCT03805932 Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03796156 Aspirin to Target Arterial Events in Chronic Kidney Disease Status TERMINATED Phase PHASE3
NCT03794596 A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer Status WITHDRAWN Phase PHASE2
NCT03794336 Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive Status COMPLETED Phase PHASE4
NCT03787927 Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets Status UNKNOWN Phase PHASE1/PHASE2
NCT03766581 A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel Status COMPLETED Phase PHASE2
NCT03698513 A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03620760 Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation Status UNKNOWN Phase PHASE4
NCT03581409 Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm Status COMPLETED Phase PHASE4
NCT03578822 Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial Status COMPLETED Phase PHASE3
NCT03574909 IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes Status COMPLETED Phase PHASE3
NCT03543683 Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC Status COMPLETED Phase PHASE2
NCT03532698 Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) Status UNKNOWN Phase N/A
NCT03487406 Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) Status COMPLETED Phase PHASE2
NCT03456960 A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet Status COMPLETED Phase PHASE1